
Hinge Health is Going Public. Is It Wise?
Amid the market volatility and intense macroeconomic uncertainty, is it wise for Hinge Health to test the public markets?
Amid the market volatility and intense macroeconomic uncertainty, is it wise for Hinge Health to test the public markets?
Transcarent is planning to acquire Accolade for $621 million, the companies announced Wednesday. The two companies are very complementary and the deal gives Accolade a chance to turn things around after struggling in the public market, experts say.